GlassScriptPhysician profile
Samuel Sanders
NPI 1427299205
$10,562.31
in general payments reported to CMS, 2019-2025
26 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,452 · 2020: $1,904 · 2021: $688 · 2022: $687 · 2023: $505 · 2024: $239 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004 · Travel and Lodging: $828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.23 |
| Travel and Lodging | $827.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,780.77 | 2019-2025 | |
| Supreme Orthopedic Systems, LLC | $1,977.01 | 2020-2025 | |
| Stryker Corporation | $1,293.21 | 2019-2025 | Hoffmann, Pangea |
| Amgen INC. | $292.58 | 2019-2025 | Evenity, Prolia |
| Medtronic USA, INC. | $272.36 | 2019-2020 | |
| Biocomposites INC | $266.57 | 2023-2025 | Stimulan |
| Ferring Pharmaceuticals INC. | $265.06 | 2019-2024 | Euflexxa |
| Smith+Nephew, INC. | $200.43 | 2019-2025 | Pico 7, Pico 14 |
| Si-Bone, INC. | $144.92 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $137.96 | 2023-2025 | Exparel, Zilretta, Iovera |
| Innovation Technologies INC | $129.44 | 2023-2025 | Irrisept |
| Biotissue Holdings INC. | $124.70 | 2022 | |
| Medtronic, INC. | $113.50 | 2021 | |
| Depuy Synthes Sales INC. | $108.29 | 2019-2024 | Emphasys |
| Bioventus LLC | $88.07 | 2019-2024 | Durolane |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $82.88 | 2019-2022 | |
| Pacira Therapeutics, INC. | $54.82 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $49.35 | 2023 | Tricera Handpiece |
| Convatec INC. | $36.08 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $32.98 | 2022 | |
| Misonix INC | $25.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.29 | 2025 | |
| Globus Medical, INC. | $18.37 | 2025 | Senza |
| Fidia Pharma USA INC. | $17.72 | 2019 | |
| Arteriocyte Medical Systems, INC. | $16.17 | 2021 | |
| Ermi LLC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.